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ABSTRACT 
The arylesterase (ARE) activity linked to the paraoxonase-1 (PON1) gene is known to protect 
lipoproteins from oxidation and provide defense against metabolic syndrome (MetS) and car-
diovascular diseases. The epigenetic regulation of enzymatic activities is gaining importance 
nowadays. This research aimed to assess the potential relationships between the ARE activity 
with the methylation levels of the PON1 gene transcriptional regulatory region, anthropomet-
rics, biochemical markers and antioxidant dietary components. Forty-seven subjects 
(47 ± 10 y.o; BMI 36.2 ± 3.8 kg/m2; 46.8 % female) with MetS features, who followed a six-
month energy-restricted dietary weight-loss intervention, were included in this study 
(www.clinicaltrials.gov; NCT01087086). Anthropometric, biochemical, enzymatic and die-
tary data were assessed using validated procedures. PON1 transcriptional regulatory region 
methylation was analyzed by a microarray technical approach. Volunteers reduced ARE ac-
tivity in parallel with body weight (p = 0.005), BMI (p = 0.006), total fat mass (p = 0.020), di-
astolic blood pressure (p = 0.018), mean blood pressure (p = 0.022) and triglycerides 
(p = 0.014). Methylation levels of some CpG sites of the PON1 gene correlated negatively 
with ARE activity (p < 0.05). Interestingly, dietary vitamin C (p = 0.001), tocopherols 
(p = 0.009) and lycopene (p = 0.038) were positively associated with ARE activity and 
showed an inverse correlation (p = 0.004, p = 0.029 and p = 0.021, respectively) with the 
methylation of some selected CpG sites of the PON1 gene. In conclusion, ARE activity de-
creased in parallel with MetS-related markers associated to the energy restriction, while die-
tary antioxidants might enhance the ARE activity by lowering the PON1 gene methylation in 
patients with MetS features.  
 
Keywords: DNA methylation, ARE, PON1 gene, obesity, metabolic syndrome, energy  
restriction, antioxidants 
 
 
EXCLI Journal 2014;13:416-426 – ISSN 1611-2156 
Received: December 20, 2013, accepted: March 14, 2014, published: April 09, 2014 
 
 
417 
INTRODUCTION 
Paraoxonase-1 (PON1) is a calcium-
dependent glycoprotein hepatically synthe-
sized that belongs to the paraoxonase fami-
ly (Precourt et al., 2011). This enzyme is re-
lated to high density lipoprotein-cholesterol 
(HDL-c) and has been described to protect 
lipoproteins, particularly low density lipo-
protein-cholesterol (LDL-c), from oxidation 
(Kim et al., 2013; Kumar et al., 2013). 
Thus, some of the antiatherogenic proper-
ties of HDL-c are attributed to PON1 func-
tions (Cohen et al., 2012). The precise 
mechanisms by which the PON1 acts re-
mains unclear, but several in vitro activities 
have been attributed to this enzyme (Nus et 
al., 2008): paraoxonase (hydrolysis of or-
ganophosphates), lactonase (hydrolysis of 
lactones), and arylesterase or ARE (hydrol-
ysis of aromatic carboxylic acid esters).  
Obesity and metabolic syndrome 
(MetS) features are main risk factors for the 
development of atherosclerosis and cardio-
vascular diseases (CVD) onset (Garg et al., 
2014). Due to the increasing prevalence of 
obese people, these accompanying diseases 
are considered a major concern for public 
health authorities and many scientific ef-
forts are being carried out to detect, treat 
and prevent them. Hypocaloric diets are one 
of the most common treatments employed 
to combat MetS and related diseases 
(Straznicky et al., 2010). However, more 
investigation is needed to understand the 
PON1 activity role as part of these nutri-
tional strategies. In this context, some re-
search have been performed focusing on the 
relationship between the PON1 activity lev-
els and the MetS/ obesity states (Ferretti et 
al., 2012; Koncsos et al., 2011; Kota et al., 
2013; Tabur et al., 2010) while other au-
thors have investigated the influence of 
some specific dietary factors on the activity 
levels of this enzyme (Canales et al., 2011; 
Jarvik et al., 2002; Vazquez-Velasco et al., 
2011). But the studies carried out are scarce 
and reported controversial results. 
Epigenetics is defined as heritable 
changes in gene expression that cannot be 
explained by changes in DNA sequence 
(Christensen et al., 2011). Among the dif-
ferent possible epigenetic modifications, 
DNA methylation is probably the most 
widely studied (Milagro et al., 2011). In 
this context, dietary factors, specially anti-
oxidants, have become agents of strong in-
terest in the field of epigenetics due to their 
prominent role as potent modulators of 
epigenome-regulated gene expression 
through regulation of DNA methylation 
(Bartels, 2007; Malireddy et al., 2012; Mil-
agro et al., 2009).  
Thus, within this scenario, the current 
study aimed to assess the potential relation-
ships between the PON1 ARE activity and 
anthropometric and biochemical markers, 
dietary antioxidants intake, and the cytosine 
methylation levels of PON1 gene transcrip-
tional regulatory region, in volunteers with 
MetS symptoms after following an energy-
restricted dietary program. 
 
MATERIALS AND METHODS 
Subjects and study protocol 
The current analysis was an ancillary 
study conducted within the RESMENA 
(Metabolic Syndrome Reduction in Navar-
ra) project, a randomized controlled trial 
(Zulet et al., 2011) where a subsample of 47 
obese adults (47 ± 10 y.o; BMI 36.2 ± 3.8 
kg/m2; 46.8 % female) who presented MetS 
features was selected. The study lasted a to-
tal of 6 months divided in two sequential 
stages: an initial 8-week nutritional-
learning intervention period, during which 
nutritional assessment was carried out for 
the participants every 15 days (Lopez-
Legarrea et al., 2013) and a 4-month self-
control period, during which the partici-
pants followed the previously acquired die-
tary habits (de la Iglesia et al., 2013). 
The study was approved by the Ethics 
Committee of the University of Navarra 
(065/2009) and appropriately registered at 
www.clinicaltrials.gov (NCT01087086). 
Consequently, all the participants gave 
written informed consent for participation 
in agreement with the Declaration of Hel-
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sinki. More details about the procedures 
and protocols have been previously report-
ed (Zulet et al., 2011).  
 
Anthropometric, body composition, blood 
pressure and dietary intake assessment 
Anthropometric measurements were 
conducted in fasting conditions according 
to previously described procedures (Zulet et 
al., 2011). Body mass index (BMI) was cal-
culated as the body weight divided by 
height squared (kg/m2). Body composition 
analyses were carried out by Dual Energy 
X-ray Absorptiometry (DXA) following 
validated protocols as reported elsewhere 
(Zulet et al., 2011). Systolic (SBP) and di-
astolic (DBP) blood pressures were meas-
ured following standardized World Health 
Organization criteria (Whitworth et al., 
2004). Mean blood pressure (MBP) was 
calculated as: [(DPB x 2) + SBP]/3 as ad-
vised elsewhere (Shapiro et al., 2010). 
Information about dietary intake was 
collected using a 48 h weighed food record 
and analysed using the DIAL (Alce Inge-
niería) software (http://www.alceingenieria. 
net/nutricion) as previously reported 
(Perez-Cornago et al., 2013). 
 
Biochemical assessments 
Venous blood samples were drawn after 
a 12 h overnight fast by venipuncture. The 
EDTA–plasma and serum samples as well 
as WBC were separated from whole blood 
by centrifugation at 3,500 rpm, 5 °C, 
15 min (Model 5804R, Eppendorf, Germa-
ny), and were frozen immediately at -80 °C 
until assay (WBC in buffy-coat).  
Plasma concentrations of triglycerides 
(TG), total cholesterol (TC), HDL-c (Wako 
Chemicals, GmbH, Nuiss, Germany) and 
glucose (Horiba ABX Diagnostics, Mont-
pellier, France) were measured by specific 
colorimetric assays, using an automated an-
alyzer system Pentra C-200 (HORIBA 
ABX, Madrid, Spain). LDL-c levels were 
calculated using the Friedewald formula:  
LDL-c = TC - HDL-c – TG/5 (Friedewald 
et al., 1972). Apolipoprotein B (Apo B) was 
measured with a specific kit (Tina-quant 
Apolipoprotein B ver.2, Mannheim, Ger-
many) using a Model 904 Modular Roche/ 
Hitachi autoanalyser (Roche Diagnostics, 
Tokio, Japan).  
Plasma concentrations of ARE activity 
were measured with simulated body fluid 
(SBF) as buffer and phenylacetate as sub-
strate at pH 7.34–7.4 and 37 °C, as pub-
lished elsewhere (Nus et al., 2006). Reac-
tion rates of ARE were followed at 270 nm 
in thermostatically controlled 10-mm 
Lightpath quartz cuvettes using a Shimadzu 
UV-2401PC spectrophotometer (Tokio, Ja-
pan). The final reaction volume in the cu-
vettes was 2.0 mL, and the total time was 
3 min. One unit of ARE activity was 
defined as the mmol phenol formed from 
phenyl acetate per min. 
 
DNA isolation and DNA methylation study 
Genomic DNA from WBC was extract-
ed using the Master Pure kit (Epicenter, 
Madison, WI, USA), whose quality was as-
sessed with PicoGreen dsDNA Quantitation 
Reagent (Invitrogen, Carlsbad, CA, USA). 
A total of 500 ng of DNA was modified by 
using EZ-96 DNA Methylation Kit (Zymo 
Research Corporation, USA) according to 
the manufacturer's instructions, converting 
thus cytosine into uracil. Array-based spe-
cific DNA methylation analysis was per-
formed with the Infinium Human Methyla-
tion 450K bead chip technology (Illumina, 
USA). Bisulfite-treated genomic DNA was 
whole-genome amplified, hybridized to 
HumanMethylation450 BeadChips (Illumi-
na, USA) and scanned using the Illumina 
iScanSQ platform (Mansego et al., 2013). 
The intensity of the images was extracted 
with the GenomeStudio Methylation Soft-
ware Module (v 1.9.0, Illumina, USA). 
Eight Cytosine-phosphate-guanine (CpG) 
sites of the PON1 gene that codes for the 
PON1 enzyme were selected. CpG sites lo-
cated in the transcriptional regulatory re-
gion (promoter, 5’-untranslated region and 
exon 1) were included (Figure 1). Refer-
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ence names and characteristics of the se-
lected CpG sites are shown in Table 1. 
 
Statistical analyses 
Results are shown as mean value ± 
standard deviation. Variable distribution 
was determined by the Shapiro-Wilk test 
and no normal variables (glucose, HDL-c, 
LDL-c, TG, ARE and ARE/HDL-c) were 
logarithmically transformed for statistical 
purposes. Differences between the begin-
ning and the end of the complete study 
were analyzed by paired Student t-test. 
Pearson correlations adjusted for age and 
sex were fitted to evaluate the potential as-
sociations of PON1 ARE activity and an-
thropometric, body composition, blood 
pressure and biochemical variables, and al-
so to assess the relationships between 
PON1 transcriptional regulatory region 
methylation and ARE activity and specific 
dietary factors. Pearson correlations adjust-
ed for sex and age were also used to study 
the association between the ARE activity 
and the dietary factors intake at the end of 
the study. Moreover, multiple testing cor-
rection (Benjamini–Hochberg) analyses 
were performed when appropriate. The 
SPSS 19.0 software (SPSS Inc., Chicago, 
IL, USA) for Windows XP (Microsoft, 
USA) was used for statistical analyses. 
Globally, p < 0.050 was considered as sta-
tistically significant.  
 
RESULTS 
Information about selected anthropo-
metric and biochemical measurements was 
recorded at baseline and at day 180 (Table 
2). After the 6-month-long trial, participants 
presented significantly lower (p < 0.001) 
values concerning anthropometric and body 
composition variables, such as body weight, 
BMI, waist circumference, WHR, total fat 
mass and android fat mass. Volunteers also 
significantly reduced the SBP, DBP and 
MBP values as well as the plasma glucose 
 
 
 
Figure 1: Genomic localization and nucleotide sequence of 8 CpG sites covered by the Illumina probe 
for the study of DNA methylation levels of PON1 promoter (from - 1330 to +104 pb). Transcription 
Start Site (TSS). 
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Table 1: Information of the selected CpG sites for each PON1 gene 
CpG ID1 Illumina ID CHR position2 Reference3 
1 cg17330251 7: 94953956 c.+63 
2 cg01874867 7: 94954059 c.-41 
3 cg20119798 7: 94954144 c.-126 
4 cg04871131 7: 94954202 c.-184 
5 cg23055772 7: 94954438 c.-420 
6 cg07809369 7: 94954455 c.-437 
7 cg17020263 7: 94955053 c.-1035 
8 cg15887283 7: 94955348 c.-1330 
1: Studied CpG identifier 
2: Genome assembly: GRCh37, Ensemble release 73.37 
3: It begins in the first nucleotide of exon 1 
 
 
Table 2: Changes in anthropometric, body composition, blood pressure, biochemical parameters and 
arylesterase (ARE) activity after 6 month-study (N = 47) 
Variable Baseline Day 180 p 
Body weight (kg) 103.5±18.7 94.8±20.1 < 0.001 
BMI (kg/m2) 36.0±4.1 32.9±4.6 < 0.001 
Waist circumference 
(cm) 112.7±12.9 104.7±14.8 < 0.001 
WHR 0.97±0.10 0.94±0.10 < 0.001 
Total fat mass (kg) 43.0±9.6 36.0±10.8 < 0.001 
Android fat mass (kg) 4.75±1.37 3.75±1.31 < 0.001 
SBP (mmHg) 151.2±17.2 134.4±13.2 < 0.001 
DBP (mmHg) 85.6±8.9 77.7±10.5 < 0.001 
MBP (mmHg) 107.4±11.1 96.6±10.5 < 0.001 
Glucose# (mmol/L) 6.77±1.90 6.16±1.41 < 0.001 
TC (mmol/L) 5.61±1.34 5.50±1.14 0.584 
HDL-c# (mmol/L) 1.13±0.28 1.22±0.32 0.011 
LDL-c# (mmol/L) 3.50±1.19 4.27±0.98 < 0.001 
ApoB (g/L) 0.94±0.27 0.88±0.21 <0.001 
TG# (mmol/L) 2.12±1.12 1.75±1.19 0.001* 
ARE# (IU/L) 483.4±241.0 461.5±217.1 0.222 
ARE/HDL-c# (IU/mmol) 436.2±189.1 393.1±174.4 0.003 
Data are mean ± SD. p values from Student t test. #Log transformed variables. BMI, 
body mass index; WHR, waist to hip ratio; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; MDP, mean blood pressure; TC, total cholesterol; HDL-c, high density 
lipoprotein cholesterol; LDL-c, low density lipoprotein cholesterol; TG, triglycerides; Apo 
B, apolipoprotein B; ARE, arylesterase. 
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(p < 0.001), Apo B (p < 0.001), TG (p = 
0.001). On the other hand, LDL-c 
(p < 0.001) and HDL-c (p = 0.011) values 
were significantly higher at the end of the 
study.  
Plasma TC and ARE activity tended to 
be reduced, although did not reach signifi-
cance, while the ARE/HDL-c ratio was sig-
nificantly decreased (p = 0.003). 
Pearson correlation analyses adjusted 
for sex and age were performed to assess 
the possible associations between the PON1 
ARE activity and the anthropometric, body 
composition, blood pressure and biochemi-
cal variables. The PON1 ARE activity lev-
els significantly correlated with TC (r = 
0.362, p = 0.016), HDL-c (r = 0.346, p = 
0.021) and Apo B (r = 0.446, p = 0.002) 
concentrations, at baseline. Moreover, sig-
nificant positive associations were found 
between changes in ARE activity and varia-
tion of body weight, BMI, total fat mass, 
DBP, MBP and plasma TG levels (Table 3). 
The association with waist circumference 
and SBP resulted in a trend towards signifi-
cance. Some of these relationships should 
be considered as explorative since after ap-
plying a multiple comparison correction, 
the statistical significance was toned down. 
Interestingly, in the case of BMI variation, 
which is one of the main variables, re-
mained statistically associated with the 
change of PON1 ARE activity.  
At the end of the intervention, the 
PON1 ARE activity measurements showed 
positive correlations with the intake of the 
selected antioxidants vitamin C (p = 0.001), 
total tocopherols (p = 0.009) and lycopene 
(p = 0.038) recorded by the 48h weighed 
food record (Figure 2). Interestingly, when 
assessing the association between the se-
lected CpG sites methylation of the PON1 
gene and the related ARE activity at base-
line (Table 4), a significant inverse correla-
tion was found concerning the PON1 CpG 
1, CpG 2, CpG 3 and CpG 4 sites with the 
enzymatic ARE activity. Moreover, these 
associations remained significant after ap-
plying the Benjamini-Hochberg test for 
multiple comparisons. 
 
Table 3: Pearson correlation analyses between 
arylesterase (ARE) activity variation and 
changes in selected anthropometric, body com-
position, blood pressure and biochemical varia-
bles. 
Variable r p 
∆ Body weight (kg) 0.473 0.005 
∆ BMI (kg/m2) 0.459 0.006*
∆ Waist circumference (cm) 0.336 0.052 
∆ WHR 0.131 0.459 
∆ Total fat mass (kg) 0.396 0.020 
∆ Android fat mass (kg) 0.020 0.910 
∆ SBP (mmHg) 0.323 0.062 
∆ DBP (mmHg) 0.402 0.018 
∆ MBP (mmHg) 0.392 0.022 
∆ Glucose# (mmol/L) 0.123 0.487 
∆ TC (mmol/L) 0.216 0.221 
∆ HDL-c# (mmol/L) 0.201 0.254 
∆ LDL-c# (mmol/L) 0.000 1.000 
∆ Apo B (g/L) 0.200 0.249 
∆ TG# (mmol/L) 0.419 0.014 
r and p values from Pearson correlations adjusted for sex 
and age. #Log transformed variables. BMI, body mass in-
dex; WHR, waist to hip ratio; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; MBP, mean blood pressure; 
TC, total cholesterol; HDL-c, high density lipoprotein choles-
terol; LDL-c, low density lipoprotein cholesterol; Apo B, 
apolipoprotein B; TG, triacilglycerides. *P-value < 0.05 after 
correcting for Benjamini–Hochberg multiple comparisons. 
 
Table 4: Pearson correlation analyses between 
arylesterase (ARE) activity and the selected 
CpG sites methylation (%) of PON1 gene at 
baseline 
CpG site r p 
CpG 1 -0.490 0.003* 
CpG 2 -0.606 < 0.001* 
CpG 3 -0.503 0.002* 
CpG 4 -0.434 0.009* 
CpG 5 -0.013 0.939 
CpG 6 -0.326 0.056 
CpG 7 -0.235 0.174 
CpG 8 -0.159 0.361 
*P-value < 0.05 after correcting for Benjamini–Hochberg 
multiple comparisons. 
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Figure 2: Associations between antioxidant die-
tary components intake and arylesterase (ARE) 
activity  
 
Finally, the analysis of the possible rela-
tionships between the antioxidant dietary 
intake and the percentage of methylation of 
the different PON1 gene CpG sites, re-
vealed a correlation between the selected 
antioxidants: vitamin C, total tocopherols 
and lycopene and the selected CpG sites at 
baseline (Figure 3). 
 
DISCUSSION 
The assessment of processes associated 
to weight loss may contribute to a better 
understanding of the metabolic and genetic 
machinery, which will benefit the imple-
mentation of personalized dietary treat-
ments. 
 
Figure 3: Statistically significant correlations 
between antioxidant dietary components intake 
and methylation (%) of PON1 gene CpG sites 
at baseline 
 
Indeed, as reported in other studies con-
cerning hypocaloric diets (Straznicky et al., 
2010), the energy-restricted intervention 
proved to be effective in improving MetS 
abnormalities except for LDL-c, which was 
higher at the end of the study. This outcome 
agrees with Clifton et al. who described that 
in some cases, LDL-c may increase despite 
weight loss (Clifton et al., 2007). Neverthe-
less, Apo B, which has been considered a 
better predictor of CVD onset than any oth-
er lipid measurement (McQueen et al., 
2008), evidenced statistically significant 
decreased levels. 
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Concerning PON1 ARE activity, it 
seems logical the positive correlation found 
with the HDL-c levels at baseline since it is 
an HDL-c related enzyme, as other studies 
have previously reported (Aksoy et al., 
2009; Mascarenhas-Melo et al., 2013; 
Tabur et al., 2010). The positive correlation 
with LDL-c and TC also agree with previ-
ous studies (Aksoy et al., 2009; Younis et 
al., 2013). 
The PON1 ARE activity was reduced in 
parallel to some anthropometric (body 
weight, BMI), body composition (total fat 
mass), blood pressure and biochemical bio-
markers (TG) related to the MetS. Although 
there is scarce research about the relation-
ship of PON1 activity and obesity or MetS, 
the studies carried out point to relate 
obese/MetS status to lower levels of ARE 
activity (Ferretti et al., 2012; Kota et al., 
2013). Nevertheless, when it comes to clin-
ical trials, in accordance to our results, a 
significant decrease of ARE activity and se-
rum PON1 protein levels after a weight loss 
intervention, as well as a significant associ-
ation between reduced PON1 and reduc-
tions in body fat has been reported (Rector 
et al., 2007). Similarly, it has been shown 
that significant depletions of all metabolic 
outcomes in addition to a significant reduc-
tion of PON1 activity correlated with BMI 
reduction, after a low calorie diet interven-
tion (Kotani et al., 2009). In this last study, 
a significant association of PON1 activity 
changes and LDL-c depletion was also ob-
served; however, no significant relation-
ships were found in the present experi-
mental trial. On the other hand, to our 
knowledge, this is the first research that has 
found an association of ARE activity and 
TG changes after a dietary intervention. 
With regards to the significant association 
of PON1 activity depletion and reduction of 
blood pressure levels, it has been reported 
significantly higher ARE levels in hyper-
tensive than in normotensive children (Akis 
et al., 2009), while in other studies carried 
out in different adult populations no associ-
ation was found (Tabur et al., 2010; Usta et 
al., 2011). However, the studies mentioned 
above were cross-sectional studies, while 
the present work is a clinical intervention. 
Taking into account the previous issues and 
the lack of research in the area, the findings 
observed in the present study may indicate 
that reductions on PON1 general activity 
might be indicative of the improvement in 
the overall MetS/obese related features, in 
patients with MetS manifestations under an 
energy-restricted programme. 
The activity of PON1 is under genetic 
and environmental regulation (Jarvik et al., 
2002). Within the environmental factors 
that may alter PON1 activity, dietary anti-
oxidants are of major importance, since 
PON1 is an oxidative stress related enzyme 
(de la Iglesia et al., 2014; Kheir-Eldin et al., 
2008). Among the different antioxidants 
that can be incorporated in the diet, the an-
tioxidant capacity of vitamins C and E and 
lycopene is well-established (Chen et al., 
2013; Mustacich et al., 2007; Story et al., 
2010). The positive relationships between 
the ARE activity and the selected antioxi-
dant components reported in the present 
work may be explained by the capacity of 
the dietary antioxidants to scavenge free-
oxygen radical products that may depress 
PON1 activity, as previous studies have 
suggested (Jarvik et al., 2002; Tsakiris et 
al., 2009). 
DNA methylation is one of the major 
epigenetic mechanisms considered to regu-
late gene expression, together with histone 
modifications and noncoding RNA activity 
(Portela et al., 2010). Methylation of the 
CpG-rich region (CpG island) overlapping 
a gene’s promoter is a generally accepted 
mechanism for silencing expression 
(Vanderkraats et al., 2013). Our findings 
confirm this outcome since four CpG sites 
and the average methylation of all the CpG 
sites studied inversely correlated with the 
ARE activity. 
About the possible mechanisms by 
which the dietary antioxidants exert their 
effects, modulation of gene expression 
through regulation of DNA methylation is 
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one of the main studied mechanisms 
(Bartels, 2007; Malireddy et al., 2012; Mil-
agro et al., 2009). In the present work, in-
verse correlations between dietary vitamin 
C, total tocopherols and lycopene with dif-
ferent CpG sites methylation was observed, 
which may influence in the ARE activity as 
other studies have suggested  (Jarvik et al., 
2002; Tsakiris et al., 2009).  
This work has the limitations that we 
have not determined PON1 methylation 
levels at the end of the intervention and we 
have not measured expression levels. How-
ever, we found that CpG2 and CpG7 sites 
match a core-binding consensus motif for 
the GATA binding protein 1 (globin tran-
scription factor 1) and CpG2 site matches 
for myeloid zinc finger 1 (MZF1), which 
are known transcriptional regulators for 
several pathways (Gaboli et al., 2001; 
Zheng et al., 2010). Furthermore, some sta-
tistical associations concerning changes in 
PON1 ARE activity and anthropometric 
and biochemical measurements variations 
were lost after the application of a multiple 
comparison correction test. 
In conclusion, the present study reports 
that ARE activity decreased in parallel with 
MetS-related markers, while dietary antiox-
idants intake may enhance the ARE activity 
by lowering the PON1 gene methylation in 
patients with MetS features, under an ener-
gy-restricted intervention. These results 
suggest that further investigations into 
PON1 activity might be a good target to 
better understand the metabolic effects of 
the dietary intervention studies, in which 
epigenetic processes may be involved. 
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